Tidefelt U, Elmhorn-Rosenborg A, Paul C, Hao XY, Mannervik B, Eriksson LC
Pregnancy itself increases the risk of gestational diabetes and preeclampsia in women with obesity, creating a complex clinical calculus: untreated obesity carries known risks, while continuing semaglutide through pregnancy lacks adequate safety data
A significant milestone for Dr
A medication that addresses those changes directly makes far more sense
In muscle tissue, IGF-1 LR3 is instrumental in increasing the DNA and RNA synthesis, which are crucial for protein synthesis and muscle cell proliferation, leading to hyperplasia (increase in the number of muscle cells) and hypertrophy (enlargement of existing muscle cells)